Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan S Zager

Showing results (51-60 of 321) with videos related to

Pageof 33
Sort By:
Annals of Surgical Oncology|December 15, 2022
Talimogene Laherparepvec in Combination with Immunotherapy, A Viable Option?Jonathan S Zager, Alexander C J van Akkooi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2020
Overestimation of Risk for Sentinel Lymph Node Metastasis in a Nomogram for T1 MelanomasGiorgos Karakousis, Vernon K Sondak, Jonathan S Zager
Journal of Surgical Oncology|March 13, 2020
Isolated limb infusion: Institutional protocol and implementationMichael J Carr, James Sun, Jonathan S Zager
Expert Opinion on Pharmacotherapy|November 9, 2014
Intralesional therapy for metastatic melanomaSarah Sloot, Omar M Rashid, Jonathan S Zager
Annals of Surgical Oncology|August 28, 2024
ASO Author Reflections: Optimizing Line of Therapy with the Melphalan/Hepatic Delivery System for Metastatic Uveal MelanomaHelana Ghali, Michelle M Dugan, Jonathan S Zager
Annals of Surgical Oncology|March 8, 2020
ASO Author Reflection: Isolated Limb Infusion for Locally Advanced Melanoma in the Extremely Old Patient is Safe and EffectiveJüri Teras, Hidde M Kroon, Jonathan S Zager
Melanoma Management|September 8, 2018
Talimogene laherparepvec: overview, combination therapy and current practicesCristina O'Donoghue, Matthew P Doepker, Jonathan S Zager
Expert Review of Anticancer Therapy|May 11, 2011
Prognostication in Merkel cell carcinomaJonathan S Zager, Dana E Rollison, Jane Messina
Journal of Surgical Oncology|December 17, 2008
Multimodality management of desmoid tumors: how important is a negative surgical margin?Marcovalerio Melis, Jonathan S Zager, Vernon K Sondak
Expert Review of Anticancer Therapy|July 16, 2020
The MAP kinase signal transduction pathway: promising therapeutic targets used in the treatment of melanomaErin McClure, Michael J Carr, Jonathan S Zager
Pageof 33

Showing results (51-60 of 321) with videos related to

Sort By:
Pageof 33
Annals of Surgical Oncology|December 15, 2022
Talimogene Laherparepvec in Combination with Immunotherapy, A Viable Option?Jonathan S Zager, Alexander C J van Akkooi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2020
Overestimation of Risk for Sentinel Lymph Node Metastasis in a Nomogram for T1 MelanomasGiorgos Karakousis, Vernon K Sondak, Jonathan S Zager
Journal of Surgical Oncology|March 13, 2020
Isolated limb infusion: Institutional protocol and implementationMichael J Carr, James Sun, Jonathan S Zager
Expert Opinion on Pharmacotherapy|November 9, 2014
Intralesional therapy for metastatic melanomaSarah Sloot, Omar M Rashid, Jonathan S Zager
Annals of Surgical Oncology|August 28, 2024
ASO Author Reflections: Optimizing Line of Therapy with the Melphalan/Hepatic Delivery System for Metastatic Uveal MelanomaHelana Ghali, Michelle M Dugan, Jonathan S Zager
Annals of Surgical Oncology|March 8, 2020
ASO Author Reflection: Isolated Limb Infusion for Locally Advanced Melanoma in the Extremely Old Patient is Safe and EffectiveJüri Teras, Hidde M Kroon, Jonathan S Zager
Melanoma Management|September 8, 2018
Talimogene laherparepvec: overview, combination therapy and current practicesCristina O'Donoghue, Matthew P Doepker, Jonathan S Zager
Expert Review of Anticancer Therapy|May 11, 2011
Prognostication in Merkel cell carcinomaJonathan S Zager, Dana E Rollison, Jane Messina
Journal of Surgical Oncology|December 17, 2008
Multimodality management of desmoid tumors: how important is a negative surgical margin?Marcovalerio Melis, Jonathan S Zager, Vernon K Sondak
Expert Review of Anticancer Therapy|July 16, 2020
The MAP kinase signal transduction pathway: promising therapeutic targets used in the treatment of melanomaErin McClure, Michael J Carr, Jonathan S Zager
Pageof 33